RESULTS Technical success 118/120 (99%). 6 lesions treated by angioplasty alone: 3 VO (first 3 pts. 2 V1, 1 V2 lesion). 1 pt (inflammatory disease) treated by cutting balloon alone. 111 lesions treated with stents (direct stenting: 96). Peripheral balloon expandable stents (n¼23), self expandable stents (n¼4 for 3 V1 and one V2 lesions). 88 coronary stents (20 DES). 1 pt developed a TIA during the procedure. No neurological complications at 30 days Clinical success 112/114 (99%) Post-procedure arterial diameter: 4,60 AE 0,8 mm (4-6). Mean residual stenosis 2,5 AE 3,9 %. In 12 pts treated with protection devices, visible debris removed in 9 (6 Filterwire, 2 Fibernet) 1 Angioguard with the same amount of debris as during Carotid Stenting) 9 pts (8%) developed a symptomatic restenosis during the follow-up (mean: 33.4.AE29.9 months), 3 after PTA alone, 5 after PTA and stent (1 occlusion treated medically, 7 stenoses successfully treated with PTA). No restenosis after DES implantation at 1 year.
CONCLUSIONS VAS can be performed safely and effectively with a high technical success rate, a low complication rate, a low restenosis rate and a durable clinical success in patients with symptomatic VA stenosis. Stents seem to improve immediate and long-term results. The role of protection devices and D.E.S has to be discussed. METHODS 407 patients (males: 245, mean age: 66.1 AE 12 y) underwent percutaneous treatment for subclavian artery (SA) occlusive disease (stenosis: 295, occlusion: 112). Left: 312, Right: 95, Innominate Artery: 28. Etiology: atheromatous: 397, others: 10 (Takayasu: 6) Mean % stenosis 83.4 þ/-7.8. Mean lesion length: 23.9 þ/-8.7 mm Indications for treatment were upper limb ischemia (ULI) (n¼177) Vertebrobasilar insufficiency (VBI) (n¼157), associated VBI and ULI (n¼123), coronary steal syndrome (n¼20) asymptomatic patients with severe coronary disease (n¼73) 39 patients had associated Vertebral Artery stenosis, 81 carotid stenoses. 337 prevertebral lesion, 45 post vertebral, both 25. Access: femoral (n¼287), brachial (n¼81), both (n¼39). "Pull through technique": 8 cases. An isolated balloon angioplasty was performed in 59 cases and 348 stents were implanted (balloon expandable: 276, self expandable: 72).
RESULTS Technical success was obtained in 387 lesions (95 %) 100% for stenoses. Only 92 occlusions were recanalized (82 %). Four periprocedural events occurred (1.2 %), 1 major (fatal stroke), 1 T.I.A., 2 arterial thromboses. During the follow-up (mean follow-up: 75.7 months AE 38.5), we had 40 restenoses (10 %). 13 occurred following angioplasty alone (18.8 %) and 27 following angioplasty and stent implantation (7.8 %) (P<0.01). 10 were treated by new angioplasty alone, 30 by repeat stent implantation. Primary (PI) and secondary (PII) patencies on an intention to treat basis at 10-year follow-up were 80.2 % and 86.5 % respectively. In patients without initial stent placement, the rates were 67.5 % and 75.5 % while in those with stents, the rates rose to 91.5 % and 98.2 % (P < 0.01). PI for all recanalized lesions were 85.8 %, 79.1 % without stent, 91.8 % with stent (P < 0.04) and PII 92.8 %, 88.5 %, 98.1% respectively (P < 0.02). CONCLUSIONS P.T.A. is currently the treatment of choice for subclavian artery lesions. It is a safe and effective procedure associated with low risks and good long-term results. Stents seem to limit the restenosis rate and improve long-term results. BACKGROUND Decreased proximal aortic distensibility predicts allcause mortality and cardiovascular events. Radial aortic distensibility is preserved after thoracic endovascular aortic repair (TEVAR), but its impact on longitudinal aortic distensibility (LAD) has not yet been elucidated. This study sought to quantify the impact of TEVAR and stent-graft oversizing on LAD in an ex-vivo porcine model.
METHODS
Twenty fresh thoracic porcine aortas were harvested and connected to a flow pump at body temperature. The anterior side of each aorta was marked every 5 cm from the left subclavian artery till the celiac trunk. LAD measurements were conducted through highdefinition imaging and custom developed software at five different pressure levels (100, 120, 140, 160 and 180 mmHg), before and after TEVAR with a 150 mm long stent-graft. Three groups of oversizing were created (0-9%, 10-19%, and 20-29%). Uniaxial tensile testing was conducted after the experiment to evaluate the elastic properties of the porcine aortas in the proximal, central and distal zones, from both circumferential and longitudinal fragments.
RESULTS After TEVAR, LAD decreased in the stented segments (11.9% vs. 5.6%, p<0.001) and in the total aorta (11.4% vs. 7.0%, p<0.001, Figure 1 ). The positive linear correlation between LAD and pressure was reduced at 120 mmHg in the stented segments (2.0% vs. 0.9%, p<0.001) and in the total aorta (2.0% vs. 1.4%, p¼0.002), and remained significant for all higher pressures (Figure 1 ). Stent-graft oversizing did not affect the level of LAD reduction (p¼0.797). Tensile testing confirmed homogeneity of aortic biomechanical responses with a mean peak stress to rupture of 1.4AE0.4 MPa and a coefficient of variation of 0.3. Moreover, mean peak stress was higher for the circumferential than for the longitudinal fragments in all three zones (2.3AE0.4 MPa vs. 1.4AE0.4 MPa, p¼0.01).
CONCLUSIONS In this ex-vivo experimental model, LAD of the healthy thoracic aorta decreased after TEVAR. Such longitudinal stiffening may impact cardiovascular function and increase the risk of cardiovascular disease and TEVAR-related complications. This study may serve as a base for future investigation on the impact of thoracic aortic stent-grafts and the cardiovascular system, and might contribute to future stent-graft design.
